Evaluate and Compare the Rate of Para-Stomal Herniation After Permanent Stoma Formation
Primary Purpose
Hernia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
mesh reinforcement of stoma
no intervention
Sponsored by
About this trial
This is an interventional prevention trial for Hernia focused on measuring stoma, hernia, mesh
Eligibility Criteria
Inclusion Criteria:
- Patients will be at least 18 years of age.
- Male or female (excluding pregnant females).
- Patients will require stoma formation.
- Patients with ASA < 3.
- Patients informed about the study, and will have read; understood and signed the patient informed consent and authorization to use their PHI, as applicable.
- Patients will be willing and able to submit to postoperative follow-up evaluations.
Exclusion Criteria:
- Patients that have had prior surgical treatment parastomal herniation.
- Patients that refuse stoma formation.
- Patients with ASA > 3.
- Patients who have certain metabolic conditions (e.g., chronic hepatic or renal disease).
- Patients with evidence of pre-existing systemic or local infections.
- Patients with wound-healing or autoimmune disorders.
- Patients who, in the surgeon's opinion, would have a difficult time comprehending or complying with the requirements of the study.
- Patients with any conditions that were not suspected preoperatively and are only discovered at the time of the operation.
Sites / Locations
- Mayo Clinic
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
2
Arm 1
Arm Description
mesh reinforcement at stoma
standard stoma
Outcomes
Primary Outcome Measures
Rate of parastomal hernia formation.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00577603
Brief Title
Evaluate and Compare the Rate of Para-Stomal Herniation After Permanent Stoma Formation
Official Title
A Controlled, Randomized Study to Evaluate and Compare the Rate of Para-Stomal Herniation After Permanent Stoma Formation With and Without Reinforcement With a Collagen Mesh
Study Type
Interventional
2. Study Status
Record Verification Date
April 2013
Overall Recruitment Status
Completed
Study Start Date
January 2006 (undefined)
Primary Completion Date
June 2011 (Actual)
Study Completion Date
June 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study is being done to evaluate the use of a material (Alloderm collagen mesh) during the stomal formation operation (surgery that will create a mouth-like opening on the surface of the body to an internal organ). The main purpose of this research study is to see if using this material will lower the hernia rate compared to normal repair without this material. The secondary purpose is to evaluate if using this material will increase or decrease complication rates.
Detailed Description
This study seeks to examine the ability of an implantable collagen matrix to reduce the incidence of parastomal hernia formation. Patients will be randomized preoperatively by a computer generated random allocation to either receive collagen mesh at the time of stoma formation, or to have stoma formation without mesh. Stomas without mesh will be made in the standard surgical fashion dictated by the type of stoma: ileostomy, colostomy, ileal conduit. Patients randomized to receive mesh will undergo stoma formation in an identical fashion, and will have a 8 cm x 12cm piece of AlloDerm mesh placed as a tissue reinforcement at the stoma site and extending under the midline incision. Patients will be followed with physical examinations at approximately 2weeks post-op, 3, 6, 9, 12, 24 months post-op, and will undergo CT scanning of the abdomen and pelvis at 12 and 24months to determine hernia occurrence.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hernia
Keywords
stoma, hernia, mesh
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
2
Arm Type
Active Comparator
Arm Description
mesh reinforcement at stoma
Arm Title
Arm 1
Arm Type
Active Comparator
Arm Description
standard stoma
Intervention Type
Procedure
Intervention Name(s)
mesh reinforcement of stoma
Intervention Description
Patients randomized to receive mesh will undergo stoma formation and will have a 8 cm x 12 cm piece of AlloDerm graft placed as a tissue reinforcement around the stoma and extending under the midline incision. The mesh will be trimmed to provide a minimum of 3cm of overlap around the stoma in all directions. The mesh will be secured with transabdominal number one Prolene (Ethicon, Inc) sutures every 4cm around the mesh. Additional fixation will be provided with Protack spiral tacks (US Surgical, Inc) every 1cm around the mesh. The midline fascia will be closed with running number one Prolene sutures. Skin will be closed in standard fashion.
Intervention Type
Other
Intervention Name(s)
no intervention
Primary Outcome Measure Information:
Title
Rate of parastomal hernia formation.
Time Frame
2 years post-op
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients will be at least 18 years of age.
Male or female (excluding pregnant females).
Patients will require stoma formation.
Patients with ASA < 3.
Patients informed about the study, and will have read; understood and signed the patient informed consent and authorization to use their PHI, as applicable.
Patients will be willing and able to submit to postoperative follow-up evaluations.
Exclusion Criteria:
Patients that have had prior surgical treatment parastomal herniation.
Patients that refuse stoma formation.
Patients with ASA > 3.
Patients who have certain metabolic conditions (e.g., chronic hepatic or renal disease).
Patients with evidence of pre-existing systemic or local infections.
Patients with wound-healing or autoimmune disorders.
Patients who, in the surgeon's opinion, would have a difficult time comprehending or complying with the requirements of the study.
Patients with any conditions that were not suspected preoperatively and are only discovered at the time of the operation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristi L Harold, MD
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85054
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Evaluate and Compare the Rate of Para-Stomal Herniation After Permanent Stoma Formation
We'll reach out to this number within 24 hrs